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Abstract Camptocormia is a highly disabling syndrome
that occurs in various diseases but is particularly associated
with Parkinson’s disease (PD). Although ﬁrst described
nearly 200 years ago, the morphological changes associ-
ated with camptocormia are still under debate and the
pathophysiology is unknown. We analyzed paraspinal
muscle biopsies of 14 PD patients with camptocormia and
compared the ﬁndings to sex-matched postmortem controls
of comparable age to exclude biopsy site-speciﬁc changes.
Camptocormia in PD showed a consistent lesion pattern
composed of myopathic changes with type-1 ﬁber hyper-
trophy, loss of type-2 ﬁbers, loss of oxidative enzyme
activity, and acid phosphatase reactivity of lesions. Ultra-
structurally, myoﬁbrillar disorganization and Z-band
streaming up to electron-dense patches/plaques were seen
in the lesions. No aberrant protein aggregation, signs of
myositis or mitochondriopathy were found, but the mito-
chondrial content of paraspinal muscles in patients and
controls was markedly higher than known from limb
biopsies. Additionally, we were able to demonstrate a link
between the severity of the clinical syndrome and the
degree of the myopathic changes. Because of the consistent
lesion pattern, we propose criteria for the diagnosis of
camptocormia in PD from muscle biopsies. The morpho-
logical changes show obvious parallels to the muscle
pathology of experimental tenotomy reported in the 1970s,
which depend on an intact innervation and do not occur
after interruption of the myotactic reﬂexes. A dysregulation
of the proprioception could be part of the pathogenesis of
camptocormia in Parkinson’s disease, particularly in view
of the clinical symptoms of rigidity and loss of muscle
strength.
Keywords Parkinson’s disease  Camptocormia 
Myopathy  Myoﬁbrillar disorganization  Proprioception
Introduction
Camptocormia (from the Greek ‘‘kamptein’’ = to bend and
‘‘kormos’’ = trunk) is an abnormal ﬂexion of the thora-
columbar spine when standing or walking that disappears
in the supine position. The syndrome, also known as ‘‘bent
spine syndrome’’, was ﬁrst described by Earle in 1815 [13]
and in some of the original cases reported by James Par-
kinson in 1817 [31]. When restricted to the cervical spine,
‘‘dropped head syndrome’’ occurs. A pronounced unilateral
involvement of muscles may lead to a laterodeviation
called Pisa syndrome. Although muscle changes similar
to camptocormia have been described for dropped head
syndrome, it is unknown whether these diseases share a
common pathomechanism.
Camptocormia can be associated with movement dis-
orders, neuromuscular diseases, spinal or metabolic
disorders or found isolated as an idiopathic condition [15,
42]. Among movement disorders it is most frequent in
idiopathic Parkinson’s disease [11], where it occurs in
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[1, 3, 26]).
The pathophysiology of camptocormia is as yet unre-
solved. It is under discussion whether the syndrome may
result from a loss of muscle strength, amyotonia of verte-
bral extensors or preponderance of ﬂexors [8, 19]. MRI
shows muscle atrophy and fatty replacement to various
degrees [5, 24, 26, 27]. The morphological ﬁndings from
paraspinal muscle biopsies of camptocormia patients
associated with different clinical diseases are heterogenous.
Mainly based on single cases or small numbers of patients,
signs of myositis, inclusion body myositis or mitochondrial
disorders were reported [9, 34, 37, 42]. In some few
patients, the camptocormia may be related to a hereditary
muscle disease [33]. In the vast majority of cases, non-
speciﬁc myopathic changes, combined with an increase of
connective tissue within muscle fascicles, were described
[4, 22, 39, 40].
We investigated paravertebral muscle biopsies from a
clinically well-deﬁned group of Parkinson patients suffering
from camptocormia. Because muscles are morphologically
different depending on their function [32], we compared the
paraspinal camptocormia biopsies with paraspinal muscle
samples from autopsies. Within the control patient group we
compared also the paraspinal sample site with a conventional
deltoidsampleanddifferentparaspinalsamplesiteswitheach
other. Autopsy samples are reported as being sufﬁcient for
histochemical and immunohistochemical staining as well as
electron microscopy within a certain postmortem time range
[14]andwerewidelyused,forexample,ascontrols[43]orfor
generating standard values [20]. In PD camptocormia
patients, we found a uniform lesion pattern in the muscle
biopsies which implies a common pathophysiological mech-
anism in camptocormia.
Patients and methods
Characterization of patients
The patients in this study suffered from idiopathic Par-
kinson’s disease and camptocormia and were prospectively
included in this study between 2004 and 2010. The diag-
nosis of Parkinson’s disease was made according to the
British Parkinson’s Disease Society Brain Bank criteria
[18]. Camptocormia is deﬁned here as a marked anterior
ﬂexion of the thoracolumbar spine of at least 30 (with
or without additional laterodeviation), appearing in the
standing or walking position and disappearing in the
recumbent position, but without any signs of a ﬁxed ky-
phosis like in osteoporotic kyphosis. Absence of clinically
detectable ﬂexor-dystonia is required. All patients were
stabilized on optimal anti-Parkinson medication. Informed
consent to take part in the study was signed by all patients.
The study was approved by the ethical committee of the
Medical Faculty of the University Hospital Schleswig-
Holstein (D 469/11).
The clinical details of our camptocormia patients were
reported by Margraf et al. [27]. Brieﬂy, the Parkinson
patients showed mean disease duration of 13.5 years. Mean
duration of camptocormia was 25 months (5–72 months).
A muscle biopsy was offered to all Parkinson patients who
had consulted the UK-SH Department of Neurology
because of their camptocormia. The muscle biopsies were
performed to determine whether the camptocormia could
be related to a treatable cause. The most affected part,
according to MR imaging of the paraspinal muscles, was
selected for the biopsy. All biopsies that were taken in the
patient group deﬁned above were used for the present
histopathological study to avoid a possible selection bias.
Details of the patients are given in Table 1.
The severity of the clinical symptoms was scored as
described by Margraf et al. [27]. This score encompasses
the inclination angle, the circumstances of occurrence, the
time of day when the symptoms occur, the degree of back
pain and the limitation in daily activities caused by the
camptocormia.
Controls
After informed consent from relatives, postmortem muscle
specimens were taken from 10 deceased patients, 5
females, 5 males, with an average age of 66.5 years
(ranging from 47 to 82 years) who died because of internal
diseases (Table 2).
Histological investigations of muscle specimens
Standard muscle evaluation was performed using stainings
of cryostat sections. These stainings included hematoxylin
and eosin (H&E), elastica van-Giesson, periodic acid Schiff
reaction (PAS), oil red O (OrO), modiﬁed Gomori tri-
chrome, nicotinamide adenine dinucleotide-tetrazolium
reductase (NADH-TR), menadione-linked a-glycerophos-
phate dehydrogenase (MAG), myoadenylate deaminase
(MAD), succinic dehydrogenase (SDH), cytochrome
oxidase (COX), combination of COX and SDH, acid phos-
phatase, non-speciﬁc esterase, adenosine triphosphatase
(ATPase) at pH values of 4.4, 4.7 and 10.4, which were
prepared according to standard procedures [12].
As indicated in the ﬁgures, quantiﬁcation per power ﬁeld
or arbitrary units were used. For counts per ﬁeld the mean
of 5–15 ﬁelds was calculated, depending on the size of the
biopsy. Nuclear bags and ﬁber splittings were counted in
medium power ﬁelds corresponding to a 200-fold magni-
ﬁcation. Ragged red ﬁbers, COX-deﬁcient ﬁbers and
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123whorled ﬁbers were counted in low power ﬁelds corre-
sponding to a 100-fold magniﬁcation. The ﬁber type
distribution was calculated by the relation of type-1 to
type-2 ﬁbers. Some changes were calculated in percent of
all ﬁbers. These were the number of ﬁbers showing internal
nuclei, the number of ﬁbers showing acid phosphatase
activity and the number of ﬁbers showing defects in the
NADH reaction. If quantiﬁcation by counting was not
applicable, a ﬁve-step rating system corresponding to
absent, mild, moderate, severe and extensive, was used.
The criteria for the semiquantitative rating were—for cal-
iber variation of myoﬁbers: 0 = uniformity, 1 = mild
variation, 2 = moderate variation, 3 = variation showing
atrophy or hypertrophic ﬁbers, 4 = variation showing
atrophy and hypertrophic ﬁbers; for endomysial ﬁbrosis:
0 = absent, 1 = ﬁbrotic sprout into endomysium, 2 = con-
tinuous ﬁne endomysial ﬁbrosis, 3 = continuous moderate
endomysial ﬁbrosis, 4 = nearly all ﬁbers were trapped by
endomysial collagen, for neurogenic atrophy: 0 = no,
1 = single atrophic ﬁbers of both types, 2 = reticular distri-
bution of some atrophic ﬁbers, 3 = several atrophic ﬁbers or
small groups, 4 = large groups of atrophic ﬁbers of both
types; for ﬁber type-2 atrophy: 0 = no, 1 = occasional,
2 = scattered but some, 3 = several, 4 = nearly all type-2
ﬁbers.
To compare the myopathic changes with clinical
symptoms, we calculated a score that includes the main
aspects of the myopathic changes. These are structural
defects, acid phosphatase activity in muscle ﬁbers, endo-
mysial ﬁbrosis, caliber variation, whorled ﬁbers, internal
nuclei and ﬁber splitting. The severity of changes for all
included parameters was standardized to a scaling system
ranging from 0 to 10. To do so, the semiquantitative values
were multiplied by 2.5, the percent values divided by 10.
All mean values of counts per power ﬁelds were within the
range of ten and were taken as they were.
Immunohistochemical stainings
All immunohistochemical staining results reported here
were obtained from frozen sections that were ﬁxed for
15 min in ice-cold acetone. With the antibody reactions
that were performed without epitope retrieval of the slides
we examined inﬂammatory reactions, lysosomal structures,
ﬁber typing, small vessels, mitochondria and protein
deposition. The following antibodies were used: CD3 (rat
monoclonal, AbD Serotec), CD8 (mouse monoclonal,
Dako), CD20 (mouse monoclonal, clone L26, Dako),
KiM1P (mouse monoclonal, gift from the Pathology
Department of UK-SH), MHC I (mouse monoclonal, clone
W6/32, Dako), cathepsin D (rabbit polyclonal, Dianova),
LAMP-1 (mouse monoclonal, clone E5, Santa Cruz),
SERCA 1 (mouse monoclonal, clone VE121G9, Thermo
Scientiﬁc), a-5-laminin (mouse monoclonal, clone 4C7,
Chemicon), prohibitin (mouse monoclonal, Abcam), sar-
comeric a-actinin (mouse monoclonal, clone EA-53,
Sigma), a-B-crystallin (rabbit polyclonal, Oncogene),
smooth muscle actin (mouse monoclonal, clone 1A4,
Beckman Coulter), dystrophin I, rod region, clone Dy4/
6D3, dystrophin II, C-terminal, clone Dy8/6C65, dystro-
phin III, N-terminal, clone Dy10/12B2 (all three were
mouse monoclonals from Novocastra), desmin (mouse
monoclonal, clone D33, Dako), ﬁlamin (mouse monoclo-
nal, clone FLMN 01, Dianova), myotilin (mouse
monoclonal, Novocastra), p62 (mouse monoclonal, BD
Bioscience), titin (mouse monoclonal, clone T11, Sigma),
triadin (mouse monoclonal, clone GE4.90, Acris-Antibod-
ies) and ZASP (rabbit polyclonal, clone LDB-3, Sigma).
For the detection of a-synuclein deposits, antibodies
LB509 (mouse monoclonal, Signet) and pSer129-a-Syn
(rabbit polyclonal, Abcam) were used. As secondary anti-
bodies, the alkaline phosphatase-coupled goat anti-mouse
or goat anti-rabbit from Dako were used and vizualized by
neufuchsine. Alternatively, the biotinylated sheep anti-
mouse or donkey anti-rabbit from GE Healthcare or rabbit
anti-rat from Dako were used, detected by horse radish
peroxidise coupled extravidin (Sigma) and vizualized by
either DAB or AEC as chromogen.
PET blot
To avoid any inﬂuence of a neurodegenerative disease on
changes in muscles of our control group, we used antibodies
against b-amyloid (clone 6E10, mouse monoclonal,
Chemicon)orphosphorylatedtau(AT8,mousemonoclonal,
Covance) to exclude individuals who showed intracerebral
protein aggregate deposits according to CERAD C or Braak
and Braak IV to VI and antibodies LB509 (Signet) and
pSer129-a-Syn (Abcam) to exclude individuals in whom
a-synuclein aggregates were detectable in the brain tissue.
For the detection of these protein aggregates, the most
sensitive PET blot method was used according to the pro-
tocol by Kramer and Schulz-Schaeffer [23]. For the
sensitive detection of a-synuclein aggregates, the autopsy
and biopsy muscles were investigated using the regular PET
blot protocol [23] and a postﬁxed frozen tissue blotting
protocol as described by Daus et al. [7].
Electron microscopic investigation
For electron microscopy, glutaraldehyde-ﬁxed specimens
were postﬁxed with 1% osmium tetroxide (Serva, Heidel-
berg, Germany) and embedded in araldite (Serva).
Ultrathin sections were contrasted with lead citrate (Serva)
and uranyl acetate (Serva). Investigations were performed
on a Zeiss EM10 transmission electron microscope (Zeiss,
Acta Neuropathol (2012) 123:419–432 423
123Oberkochen, Germany) equipped with a MegaView III
imaging system (Olympus Soft Imaging Systems GmbH,
Mu ¨nster, Germany).
Results
Histologically, paraspinal muscles differ from limb
muscles
Because different biopsy sites may vary in their histolog-
ical picture, we compared the paraspinal muscle specimens
of 10 control patients with those of their deltoid muscles.
Paraspinal muscles displayed a higher number of ragged
red and COX-deﬁcient ﬁbers than deltoid muscles in the
same control patients. Ragged red ﬁbers (RRF) were
observed in paraspinal muscles as frequently as 0.125–1.6
RRF (mean 0.66) per low power ﬁeld (LPF), whereas in
deltoid muscles, they ranged from 0 to 0.5 RRF (mean 0.2)
per LPF. COX-negative ﬁbers varied between 0 and 20
(mean 5.19) per LPF in paraspinal muscles and between 0
and 8.2 deﬁcient ﬁbers (mean 1.58) in deltoid muscles
(Fig. 1a). In paraspinal muscles, the ﬁber type ratio varied
among the fascicles more considerably than in the deltoid
muscles and more frequently showed a preponderance of
type-1 ﬁbers. No systematic differences could be observed
when comparing cervical (C7) and lumbar (L2) paraspinal
muscle samples (Fig. 1b). Muscle pathology, if present,
was always detectable in the paraspinal and deltoid sam-
ples (Table 2).
Camptocormia in Parkinson’s disease presents
with uniform muscle pathology
Using light microscopy, all 14 muscle specimens obtained
from PD camptocormia patients showed myopathic chan-
ges, i.e. increased variability in ﬁber size (Fig. 2a),
hypertrophy of type-1-ﬁbers (deﬁned as signiﬁcant increase
of ﬁber diameters compared to controls, as demonstrated in
Fig. 2g), more than 5% ﬁbers containing internalized
nuclei (ranging from 5 to 65%), rounded ﬁber shape, a
distinct number of nuclear clumps and variable, but always
detectable, endomysial ﬁbrosis (Fig. 2c) as well as focally
detectable replacement by fat cells in severely affected
camptocormia muscles. The myopathic changes were pre-
dominantly seen in type-1 ﬁbers.
These non-speciﬁc changes were accompanied by central
disarrangements of the sarcoplasmic reticulum in up to 25%
of ﬁbers, leading to a depletion of oxidative enzymes in
these ﬁbers (Fig. 3a) which were visible in NADH-TR,
SDH, COX and MAG reactions, and in some ﬁbers in
ATPases but not in the MAD reactions. Almost exclusively,
type-1 ﬁbers were affected, regardless of the amount of
type-2 ﬁbers seen in the tissue. The defects were most often
centrally located, round to oval in shape and showed a well-
deﬁned border. No densiﬁcations, fuchsinophilic structures,
Fig. 1 Morphological
differences between paraspinal
and limb muscles in controls.
Paraspinal muscles display a
higher number of ragged red
and COX-deﬁcient ﬁbers than
deltoid muscles of the same
control patients (a). No further
morphological differences were
detectable between paraspinal
muscles of cervical or lumbar
levels (b)
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123Fig. 2 Myopathic changes in
paraspinal muscles of
camptocormia compared to
controls: Increased ﬁber size
spectrum (a H&E) and
hypertrophy (g), endomysial
ﬁbrosis (c elastica van Gieson
stain) and lack of type-2 ﬁbers
(e SERCA1 immuno-
histochemistry) in
camptocormia compared to
controls (b, d, f). Quantiﬁcation
of morphological changes are
shown in h. Bar 100 lm
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123PAS-positive deposits or vacuoles were visible in the
lesions. In all PD camptocormia biopsies, the acid phos-
phatase reaction showed an intense, ﬁnely granular
reactivity in the areas of depletion of enzyme reaction
(Fig. 3c). The acid phosphatase reaction seemed to have
preceded structural defects, as it was seen in more ﬁbers
than those showing enzymatic defects.
By electron microscopy, we were able to observe
myoﬁbrillar sarcoplasmic structures being destroyed in
those lesions that were identiﬁed by light microscopy as
having oxidative depletion. Z-band streaming, developing
to electron-dense patches/plaques, were seen, but not
cytoplasmic bodies (Fig. 3e, f). In some areas, myoﬁbrillar
elements were completely disorganized. Triads were dis-
placed and were found among pathological sarcoplasmic
structures. Mitochondria were found in reduced numbers
within the lesions, but appeared normal in ﬁne structure.
The number of lysosomes was variable but not sufﬁcient to
explain the acid phosphatase reaction. Inclusions within
muscle ﬁber nuclei were not found.
Additionally, in 9 of 12 evaluable PD camptocormia
biopsy specimens, hypertrophic ﬁbers with a whorled,
‘‘ﬁngerprint-like’’ appearance were seen by light micros-
copy. These ﬁbers were seen at a frequency of one to 40
ﬁbers per 10 LPF (Fig. 2h). Whorled ﬁbers, as well as the
ﬁbers with a central loss of enzyme activity, did not stain
dark in the non-speciﬁc esterase reaction.
Histochemical reactions (MAG) showed type-1 pre-
dominance, with more than 90% of type-1 ﬁbers in 6 of 12
biopsy specimens. The type-2 ﬁber loss could be conﬁrmed
using an antibody against SERCA1 (Fig. 2e, f). Small
ﬁbers and nuclear clumps were mostly detectable with the
SERCA1 antibody.
COX, SDH as well as ATPase reactions in general were
reduced in paraspinal muscles of PD camptocormia
patients. A marked loss of ATPase activity was observed in
4 of 12 samples. Lipid contents by oil red O staining were
reduced compared to controls (Fig. 4e).
In the control samples, we did not observe a reduction
in enzyme activity, myopathic changes such as in PD
Fig. 3 Camptocormia is
characterized by myoﬁbrillar
disorganization. Loss of
oxidative enzyme reaction
(a NADH reaction)
accompanied by pathological
acid phosphatase reactivity
(c) are detectable but not in
controls (b, d).
Ultrastructurally, myoﬁbrillar
disorganization, Z-band
streaming and electron-dense
patches correspond to the light
microscopic lesions (e semithin
section, Richardson staining,
f electron microscopy). Bars
a–d 100 lm, e 25 lm, f 1 lm
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123camptocormia or multiple acid phosphatase-reactive myo-
ﬁbrillar lesions (Figs. 2b, d, 3b, d). Although in 50% of the
controls structural alterations in the oxidative enzymes
were visible in single ﬁbers and one control patient showed
an enhanced acid phosphatase reaction in single ﬁbers, no
ultrastructural myoﬁbrillar alterations were seen.
Investigating changes that may reﬂect the etiology
of PD camptocormia
To understand the etiology of the lesions found in all PD
camptocormia muscle biopsies, we studied whether the
areas of myoﬁbrillar disarrangement accumulate proteins,
whether the acid phosphatase-stained structures contained
lysosomes and whether we could detect changes in the
capillary blood supply.
We did not identify aggregation of desmin, dystrophin
(C-, N-terminal, rod domain), sarcomeric a-actinin, a-B-
crystallin, ﬁlamin, myotilin, titin, triadin and ZASP. With
antibodies detecting protein aggregates in neurodegenerative
diseases, i.e. ubiquitin, a-synuclein, S129-phosphorylated
a-synuclein, Ab, hyperphosphorylated tau and prion protein,
no speciﬁc staining was seen in muscle ﬁbers. Even with
modiﬁcations of the PET blot technique for the detection of
protein aggregates in muscle tissues [7], no a-synuclein
aggregates were detectable in muscle ﬁbers.
The dust-like acid phosphatase-stained structures in
abnormal muscle ﬁbers did not react with antibodies
against lysosomal markers LAMP1 or cathepsin D and
non-speciﬁc esterase activity was not enhanced. In single
ﬁbers that contained acid phosphatase-reactive myoﬁbril-
lar lesions, an immunoreaction was observed with the
Fig. 4 Camptocormia shows no
evidence for mitochondriopathy
or inﬂammation. Modiﬁed
Gomori’s trichrome stain
sometimes shows a higher
content of ragged red and
COX-deﬁcient ﬁbers in PD
camptocormia biopsy tissues
(a, e) than in control limb
muscles (see Fig. 1) but the
same holds true for the
paraspinal control muscles
(b, e). No evidence for
inﬂammation was
observed (c, d MHC-1
immunohistochemistry).
Bars 100 lm
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123antibody P62 against a peptide of the human ubiquitin
interactive motif (UIM).
The small capillaries around muscle ﬁbers were irreg-
ular in distribution, as was demonstrated using antibodies
against a-5-laminin and MHC I (Fig. 4c). We could
observe single ﬁbers or groups of muscle ﬁbers with fewer
capillaries around them. However, we were neither able to
co-localize a capillary loss to ﬁber lesions nor able to ﬁnd a
statistical difference in the capillary-to-muscle ﬁber ratio
between PD camptocormia biopsy tissues and controls. It
was obvious from our PD camptocormia biopsy specimens
that the capillaries around muscle ﬁbers were accompanied
by an increased amount of connective tissue compared to
those in controls. With these results we cannot rule out that
a reduced blood supply to muscle ﬁbers may be responsible
for the myopathic changes, but we have no evidence for it.
Paraspinal muscles in camptocormia do not present
signs of inﬂammation or mitochondriopathy
Using antibodies against CD3, CD8 and CD20, no inﬂam-
matory inﬁltrates were identiﬁed amongst the camptocormia
specimens, whereas in the control group four specimens
showed clearly visible lymphocytic inﬁltrates. Modiﬁed
Gomori’s trichrome stain illustrating mitochondrial content
of muscle ﬁbers showed single ragged red ﬁbers in the PD
camptocormia biopsy tissues, but the number was even
lower compared to those in controls (mean values 0.66
RRF/LPF vs. 0.3 RRF/LPF, Fig. 4a, b, e). A comparable
result was obtained with SDH/COX preparations, which
showed more COX-deﬁcient ﬁbers in the control group than
in PD camptocormia patients (mean values 5.19 vs. 1.95
COX-deﬁcient ﬁbers per LPF). An increased accumulation
of mitochondria in the subsarcolemmal zone was accom-
panied by a lack of mitochondrial staining in the center of
these ﬁbers using trichrome staining and anti-prohibitin
immunohistochemistry.
Angular atrophic ﬁbers could not be found in PD
camptocormia biopsy muscles (except in one patient),
whereas amongst controls, ﬁve patients had angular
atrophic ﬁbers. Grouping of ﬁber types as a sign of rein-
nervation was found in none of the PD camptocormia
biopsy muscles.
Correlation of the severity of myopathic changes
with clinical parameters of camptocormia
We tested whether the severity of myopathic changes as
measured by the amount of acid phosphatase-reactive ﬁbers
or the numbers of ﬁbers showing structure defects in the
NADH reaction, the ﬁbrosis, the degree of ﬁber type uni-
formity measured by the relation of the ﬁber types or a
myopathy score that contains the most relevant parameters
of the myopathic changes, correlate with either the angle of
ﬂexion, the duration of the camptocormia or the clinical
camptocormia score as suggested by Margraf et al. [27]. For
most of the parameters no signiﬁcant correlation could be
demonstrated, for example as shown for the inﬂuence of the
ﬁbrosis on the inclination angle (Fig. 5a). Although our
patient numbers are relatively small for statistically analy-
ses, we found a statistical relevant correlation between the
degree of ﬁbrosis and the clinical camptocormia score as
well as a correlation between our myopathy index and the
clinicalcamptocormiascore(Fig. 5b,c;thresholds:r[0.559;
p\0.05).
Summarizing our results, we have found evidence that
camptocormia in PD is linked to a myopathy characterized
by a typical lesion pattern that leads to a muscular insuf-
ﬁciency. Based on our ﬁndings, we propose criteria typical
of camptocormia in biopsied paraspinal muscles as shown
in Table 3.
We do not assert that these myopathological ﬁndings
can occur exclusively in camptocormia. Together with the
clinical symptom of bent spine, we suggest that the diag-
nosis camptocormia can be made if the main features are
fulﬁlled. The minor features can usually be found to a
variable extent but are alone not sufﬁcient for making the
diagnosis because of their nonspeciﬁcity. The occurrence
Fig. 5 Correlating the severity of myopathic changes with clinical
parameters of camptocormia, no signiﬁcant correlation of the
endomysial ﬁbrosis could be found with regard to the inclination
angle (a). But there was a statistically relevant correlation between
the degree of endomysial ﬁbrosis and the clinical camptocormia
score, as well as a correlation between our myopathy index which was
based on the relevant myopathological changes and the clinical
camptocormia score (b, c thresholds: r[0.559; p\0.05)
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123of ragged red and COX-negative ﬁbers in paraspinal muscles
is per se not sufﬁcient for diagnosing a mitochondriopathy in
paraspinal muscles because of its frequent occurrence in
control muscles. The proposed criteria need to be further
evaluated in independent cohorts.
Discussion
In the present study we describe a morphologically well-
deﬁned disease pattern in patients suffering from Parkin-
son’s disease and camptocormia. None of these changes is
speciﬁc by itself, but the same combination of changes—
although to various extents—was seen in all PD campto-
cormia patients (Table 1).
The muscle changes are sufﬁcient to explain the muscle
weakness of camptocormia. We observed in several muscle
ﬁbers a loss of the structural integrity of myoﬁbrils. These
ﬁbers are characterized by central areas of myoﬁbrillar
disorganization which were seen in parallel to a loss of
oxidative enzyme reaction. The structural defects showed
acid phosphatase reactivity, although these changes were
not accompanied by an increased number of lysosomes that
were detectable immunohistochemically or by electron
microscopy. The reduced number of intact myoﬁbers may
lead to an impaired ability to keep the trunk in an upright
position.
It is an open question whether the myopathy is the pri-
mary cause of camptocormia in PD. We were able to show
a correlation between the severity of the endomysial
ﬁbrosis alone or a myopathy score containing a rating of
different myopathic changes and the severity of the
camptocormia measured by the camptocormia score of
Margraf. There is no signiﬁcant correlation between the
number of muscle ﬁbers that contain lesions and any
clinical parameter. This ﬁnding parallels that in which the
number of cores in central core disease likewise shows no
correlation with the disease [45]—although the cores are
linked to the pathogenesis of the central core disease. In
conclusion, our ﬁndings suggest that the physical impair-
ment by the camptocormia is related to the severity of the
myopathic changes and shows for the ﬁrst time a link
between the clinical syndrome and the myopathy.
Type-1 predominance, ﬁber defects lacking oxidative
enzyme activities and the myoﬁbrillar disorganization may
lead to the differential diagnoses of central core disease,
myoﬁbrillarmyopathyornemalinemyopathy.Usingabattery
of antibodies, we could not ﬁnd protein aggregation like in
myoﬁbrillary myopathies within the lesions. The myopatho-
logical changes in camptocormia differ from those of central
core disease by lacking the type-1 ﬁber hypotrophy—in
contrast,weobserveatype-1ﬁberhypertrophy—andtheacid
phosphatase reactivity of the lesions that cannot be seen in
central core disease. In nemaline myopathy, an acid phos-
phatase reactivity within lesioned ﬁbers has been described
although in a completely different distribution than in camp-
tocormia [29], even when a nemaline myopathy may be the
cause of camptocormia in PD, as described in a single case
[30]. With electron microscopy, numerous small autophagic
vacuoleshavebeendetectedinthecores[29],whichcannotbe
seenincamptocormia.Nevertheless,adegradationofproteins
may take place in the muscle ﬁber lesions seen in campto-
cormia. In single ﬁbers a reactivity with an antibody against
p62, also known as sequestome 1, was observed. This is a
polyubiquitinchainbindingproteinthatshuttlessubstratesfor
proteasomal degradation [36].
As we could ﬁnd a consistent lesion pattern in PD camp-
tocormia, we checked whether these changes have been seen
byothers.Inmostreportsofcamptocormiathemusclebiopsy
results were not presented in detail. When histochemical
investigations were reported, they frequently highlighted
single aspects of the lesion pattern we report here. Lava and
Factor [25] reported moth-eaten ﬁbers and disruption of the
intermyoﬁbrillar network; Schabitz et al. [34] found myo-
pathic changes in all and selective type II ﬁber loss,
disturbance of mitochondrial distribution and sarcomere
destruction ina subsetofpatients;Spuler etal.[39]d e s c r i b e d
the same changes, including loss of NADH enzyme activity
and myoﬁbrillar disarrayin halfoftheir biopsy specimens. In
our biopsy tissues there was no evidence that the defects of
muscle structure reﬂected a protein surplus myopathy as
suggested by Spuler et al. [39].
Why is the interpretation of paraspinal muscle biopsies
so heterogenous?
It may contribute to the confusion in the ﬁeld that only a few
results have been published on the ‘‘normal appearance’’
Table 3 Histopathological diagnosis of camptocormia in Parkinson’s
disease
Main features of the histopathological diagnosis of camptocormia are
structural defects that
Are pale in oxidative enzyme reactions (i.e. SDH, NADH, COX)
Are acid phosphatase reactive
Show a myoﬁbrillar disintegration, Z-band streaming or rod-like
structures in the lesions by electron microscopy
Minor features of the diagnosis of camptocormia are
An increase of caliber variation, type 1-ﬁber hypertrophy and type
1-ﬁber predominance
Endomysial ﬁbrosis
Whorled ﬁbers
Increased number of internalized nuclei
Atrophy and loss of type 2-ﬁbers
Nuclear bags
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123of paraspinal muscles in the elderly. Only Wharton
et al. [43] investigated cervical paraspinal muscles in 23
consecutive necropsies and found ragged red ﬁbers in
60–70%, and also core-targetoid ﬁbers in some patients
over 60 years of age as well as mild focal endomysial
chronic inﬂammation in 13%. Although it is known that the
number of ragged red ﬁbers increases with age [28], we and
others [4] found a higher number of ragged red ﬁbers in
paraspinal muscles than in the limb muscles usually biop-
sied. We speculate that this physiologically high number of
ragged red ﬁbers in paraspinal muscles is the reason why the
diagnosis of a mitochondriopathy was made in several
camptocormia patients [17, 34, 46]. The relative frequency
of incidental focal chronic endomysial inﬂammation
reported for paraspinal necropsy muscles [43] shows that
inﬂammatory inﬁltrates should not be overestimated. This
is of importance since the justiﬁcation for biopsies in
camptocormia patients, in most cases, is to conﬁrm or rule
out a treatable myositis that causes the clinical symptoms.
We conclude that ragged red ﬁbers, rimmed vacuoles,
COX-deﬁcient ﬁbers and sparse inﬁltrates of lympho-
cytes may be found randomly in paraspinal muscles and
are not contradictory to the diagnosis of camptocormia
myopathy.
Is camptocormia due to an overuse myopathy?
Because the camptocormia-associated paraspinal muscles
show an increase in muscle tone, exercise-induced muscle
damage may be the cause of camptocormia. Exercise-
induced muscle damage was studied in the 1980s and
Armstrong et al. [2] observed myoﬁbrillar destruction, ﬁber
necroses, macrophage reaction or inﬂammation as related
pathological changes, whereas Z-disk streaming and
A-band disorganization was shown by Friden et al. [16].
These changes differ from those in our PD camptocormia
patients, as the hallmark of the myopathy is not ﬁber
necrosis, inﬂammation or macrophage reaction.
Is camptocormia due to proprioceptive dysregulation?
The function of paraspinal muscles is to support our
upright body position. This posture is largely regulated by
involuntary reﬂex mechanisms involving mono- and
polysynaptic reﬂexes. Additionally, central mechanisms
can inﬂuence the muscle tone via the polysynaptic reﬂexes
[35]. It has been suggested that movement disturbances in
PD may be inﬂuenced by an impaired load-receptor
mechanism. It is known that PD patients underestimate the
amplitude of joint motion as a consequence of abnormal
proprioception. They demonstrated poorer accuracy and a
higher detection threshold for passive movement of a joint
as compared to controls (reviewed in [6]). It is further
suggested that an impaired supraspinal control of spinal
interneuronal circuits inﬂuences muscular load-receptors
[10]. Consistently, an impaired proprioception of the axial
musculature was recently found in PD patients that corre-
lates with the severity of the UPDRS motor score [44]. This
led us to the hypothesis that camptocormia may be due to a
reduced load sensitivity or proprioceptive dysregulation of
paraspinal muscles.
Surprisingly, a lesion pattern in muscles, similar to
what we have found in our PD camptocormia patients, has
been observed after tenotomy. Experimental tenotomy
leads to core-like lesions in the center or periphery of
almost exclusively type-1 ﬁbers, which show an increase
in acid phosphatase activity but no autophagic vacuoles
[21]. Fibers of the tenotomised muscle lack ATPase and
SDH activity [38]. Ultrastructurally, the core-like lesions
have no normal register of sarcomeres and often thick
ﬁlaments appear more disintegrated than thin ones.
Z-band streaming and electron-dense patches/plaques can
be observed. Mitochondria are reduced in the lesions
[38]. These changes cannot be observed in denervated
tenotomised muscles or in tenotomised muscles after
chordotomy [21]. Obviously, the experimental lesions
depend on disturbances of muscle tension reﬂex mecha-
nisms, but the reﬂexes need to be functionally intact. The
lesions described in the tenotomy experiments are strik-
ingly similar to the lesions that we describe here for
camptocormia. They show not only the lack of oxidative
enzymes, but also the acid phosphatase reactivity and
ultrastructurally the myoﬁbrillar disorganization. These
similarities point to the likelihood that camptocormia
may also be related to a proprioceptive dysregulation. A
proprioceptive dysregulation may explain the clinical
symptoms of rigidity and loss of muscle strength in
camptocormia.
We examined whether we could ﬁnd changes in muscle
spindles, as they are involved in the reﬂex mechanisms.
Unfortunately, it was not possible to analyze them in suf-
ﬁcient numbers in the current biopsies. We intend to do this
in further studies on autopsy specimens.
Conclusion
Our ﬁndings suggest that camptocormia in PD is most
frequently related to a myopathy. The myopathy can be
deﬁned by pathological core features that were present in
all our cases. The myopathological changes may explain
the loss of muscle strength as they show a disorganization
of myoﬁbers. Additionally, the myopathological changes
seem to correlate with the severity of camptocormia
symptoms.Thecauseofthismyopathy,however,stillneedsto
be discovered.
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